Clinical Trial Update: A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluated ustekinumab in pediatric patients with moderately to severely active Crohn's disease. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• USTEKINUMAB (USTEKINUMAB)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Crohn Disease | Phase 1 | Status: COMPLETED